Small peptides activate the latent sequence-specific DNA binding function of p53
- PMID: 7585941
- DOI: 10.1016/0092-8674(95)90165-5
Small peptides activate the latent sequence-specific DNA binding function of p53
Abstract
Normal cells contain p53 protein in a latent state that can be activated for sequence-specific transcription by low levels of UV radiation without an increase in protein levels. Microinjection of cells with an antibody specific to the C-terminal negative regulatory domain can activate the function of p53 as a specific transcription factor in the absence of irradiation damage, suggesting that posttranslational modification of a negative regulatory domain in vivo is a rate-limiting step for p53 activation. Small peptides derived from the negative regulatory domain of p53 have been used as biochemical tools to distinguish between allosteric and steric mechanisms of negative regulation of p53 tetramer activity. Presented is the development of a highly specific peptide activation system that is consistent with an allosteric mechanism of negative regulation and that forms a precedent for the synthesis of novel low molecular mass modifiers of the p53 response.
Similar articles
-
Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases.Cold Spring Harb Symp Quant Biol. 1994;59:195-206. doi: 10.1101/sqb.1994.059.01.024. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587070
-
Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner.J Biol Chem. 1995 Jul 28;270(30):18165-74. doi: 10.1074/jbc.270.30.18165. J Biol Chem. 1995. PMID: 7629129
-
DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site.Oncogene. 1998 Aug 27;17(8):1045-52. doi: 10.1038/sj.onc.1202014. Oncogene. 1998. PMID: 9747884
-
Signaling to p53: breaking the posttranslational modification code.Pathol Biol (Paris). 2000 Apr;48(3):227-45. Pathol Biol (Paris). 2000. PMID: 10858956 Review.
-
Post-translational modifications and activation of p53 by genotoxic stresses.Eur J Biochem. 2001 May;268(10):2764-72. doi: 10.1046/j.1432-1327.2001.02225.x. Eur J Biochem. 2001. PMID: 11358490 Review.
Cited by
-
Posttranslational phosphorylation of mutant p53 protein in tumor development.Med Mol Morphol. 2006 Jun;39(2):79-87. doi: 10.1007/s00795-006-0320-0. Med Mol Morphol. 2006. PMID: 16821145 Review.
-
CP-31398, a putative p53-stabilizing molecule tested in mammalian cells and in yeast for its effects on p53 transcriptional activity.J Negat Results Biomed. 2004 Nov 17;3:5. doi: 10.1186/1477-5751-3-5. J Negat Results Biomed. 2004. PMID: 15548325 Free PMC article.
-
Loss of heterozygosity of the p53 gene and deregulated expression of its mRNA and protein in human brain tumors.Mol Cell Biochem. 2007 Jun;300(1-2):101-11. doi: 10.1007/s11010-006-9374-5. Epub 2006 Dec 16. Mol Cell Biochem. 2007. PMID: 17180249
-
Inhibition of stress-inducible kinase pathways by tumorigenic mutant p53.Mol Cell Biol. 2003 Jan;23(1):322-34. doi: 10.1128/MCB.23.1.322-334.2003. Mol Cell Biol. 2003. PMID: 12482984 Free PMC article.
-
Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide.Biochem Biophys Res Commun. 2008 Apr 4;368(2):350-6. doi: 10.1016/j.bbrc.2008.01.093. Epub 2008 Jan 28. Biochem Biophys Res Commun. 2008. PMID: 18230339 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
